[go: up one dir, main page]

AP2009004954A0 - 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer - Google Patents

2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer

Info

Publication number
AP2009004954A0
AP2009004954A0 AP2009004954A AP2009004954A AP2009004954A0 AP 2009004954 A0 AP2009004954 A0 AP 2009004954A0 AP 2009004954 A AP2009004954 A AP 2009004954A AP 2009004954 A AP2009004954 A AP 2009004954A AP 2009004954 A0 AP2009004954 A0 AP 2009004954A0
Authority
AP
ARIPO
Prior art keywords
pyrimidinederivatives
hsp
cer
pyrrolo
dihydro
Prior art date
Application number
AP2009004954A
Other languages
English (en)
Inventor
Luke Raymond Zehnder
Buwen Huang
Michael John Bennett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP2009004954A0 publication Critical patent/AP2009004954A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2009004954A 2007-02-06 2008-01-25 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer AP2009004954A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88843307P 2007-02-06 2007-02-06
US2066108P 2008-01-11 2008-01-11
PCT/IB2008/000200 WO2008096218A1 (fr) 2007-02-06 2008-01-25 Dérivés de 2-amino-5,7-dihydro-6h-pyrrolo[3,4-d]pyrimidine en tant qu'inhibiteurs de la hsp 90 pour le traitement du cancer

Publications (1)

Publication Number Publication Date
AP2009004954A0 true AP2009004954A0 (en) 2009-08-31

Family

ID=39367692

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004954A AP2009004954A0 (en) 2007-02-06 2008-01-25 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer

Country Status (22)

Country Link
US (1) US20100093696A1 (fr)
EP (1) EP2118111B1 (fr)
JP (1) JP4523073B2 (fr)
KR (1) KR20090116789A (fr)
AP (1) AP2009004954A0 (fr)
AT (1) ATE502944T1 (fr)
AU (1) AU2008212645A1 (fr)
BR (1) BRPI0807165A2 (fr)
CA (1) CA2677365A1 (fr)
CO (1) CO6220971A2 (fr)
CR (1) CR10963A (fr)
CU (1) CU20090141A7 (fr)
DE (1) DE602008005715D1 (fr)
DO (1) DOP2009000200A (fr)
EA (1) EA200970669A1 (fr)
EC (1) ECSP099565A (fr)
IL (1) IL200169A0 (fr)
MA (1) MA31170B1 (fr)
MX (1) MX2009008386A (fr)
NI (1) NI200900155A (fr)
TN (1) TN2009000329A1 (fr)
WO (1) WO2008096218A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2331544A1 (fr) * 2008-08-13 2011-06-15 Pfizer Inc. Composés 2-amino pyrimidine comme inhibiteurs puissants de l'hsp-90
GB0907284D0 (en) 2009-04-28 2009-06-10 Queen Mary & Westfield College Compounds for inducing cellular apoptosis
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
CA2788450A1 (fr) 2009-12-30 2011-07-07 Arqule, Inc. Composes naphthalenyl-pyrimidine substitues
EP2752201A1 (fr) * 2013-01-04 2014-07-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibiteurs de HSP90 C-terminal pour traiter les adénomes hypophysaires
EP2970104B1 (fr) 2013-03-14 2019-04-24 Zeno Royalties & Milestones, LLC Composés analgésiques bicycliques
JP6542794B2 (ja) 2013-12-12 2019-07-10 ゼノ ロイアルティー アンド マイルストーンズ リミテッド ライアビリティー カンパニー 二環式アルキル化合物、および合成
US10654812B2 (en) 2014-03-07 2020-05-19 Recurium Ip Holdings Llc Propellane derivates and synthesis
CN106687114B (zh) 2014-06-13 2021-08-31 尤马治疗公司 嘧啶化合物及其使用方法
CA2961605C (fr) 2014-09-17 2023-01-10 Kalyra Pharmaceuticals, Inc. Composes bicycliques
US10227029B2 (en) * 2015-08-07 2019-03-12 Kawasaki Jukogyo Kabushiki Kaisha Container holder attached to utility vehicle
CA3063729A1 (fr) 2017-05-15 2018-11-22 Recurium Ip Holdings, Llc Composes analgesiques
WO2020243457A1 (fr) * 2019-05-29 2020-12-03 Viogen Biosciences, Llc Composés et leurs utilisations thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
EA005996B1 (ru) 2000-02-15 2005-08-25 Сьюджен, Инк. Пирролзамещенный 2-индолинон, фармацевтическая композиция (варианты), способ модулирования каталитической активности протеинкиназы, способ лечения или профилактики нарушения в организме, связанного с протеинкиназой
JP4469179B2 (ja) * 2002-01-23 2010-05-26 バイエル ファーマセチカル コーポレーション Ｒｈｏキナーゼ阻害剤としてのピリミジン誘導体
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
CA2602257A1 (fr) * 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyle pyrrolopyrimidines et analogues associes en tant qu'inhibiteurs de hsp90

Also Published As

Publication number Publication date
DE602008005715D1 (de) 2011-05-05
US20100093696A1 (en) 2010-04-15
ECSP099565A (es) 2009-09-29
NI200900155A (es) 2010-06-30
MA31170B1 (fr) 2010-02-01
ATE502944T1 (de) 2011-04-15
CA2677365A1 (fr) 2008-08-14
MX2009008386A (es) 2009-10-16
JP2010518066A (ja) 2010-05-27
BRPI0807165A2 (pt) 2014-05-06
WO2008096218A1 (fr) 2008-08-14
KR20090116789A (ko) 2009-11-11
IL200169A0 (en) 2010-04-15
TN2009000329A1 (fr) 2010-12-31
AU2008212645A1 (en) 2008-08-14
JP4523073B2 (ja) 2010-08-11
EP2118111B1 (fr) 2011-03-23
EA200970669A1 (ru) 2010-02-26
EP2118111A1 (fr) 2009-11-18
DOP2009000200A (es) 2009-09-15
CU20090141A7 (es) 2011-04-26
CR10963A (es) 2009-08-27
CO6220971A2 (es) 2010-11-19

Similar Documents

Publication Publication Date Title
AP2009004954A0 (en) 2-amino-5, 7-dihydro-6H-pyrrolo [3,4-D] pyrimidinederivatives as HSP-90 inhibitors for treating can cer
IL195238A0 (en) Pyrazolo [1,5-a]pyrimidines as cdk inhibitors
IL257418A (en) Methods for treating addiction
IL211136A0 (en) Pyrido [5,4-d] pyrimidines as cell proliferation inhibitors
HRP20130799T1 (en) 8-heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as pi-3 kinases inhibitors
TWI372625B (en) Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
ZA200900109B (en) Pyrrolotriazine kinase inhibitors
GB0814904D0 (en) Search, transfer and bookign tool for multiple reward programs
ZA201004368B (en) Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors
IL226486A (en) Converted pyrazolopyrimidine compounds
SI1893612T1 (sl) Pirolo b piridin derivati kot protein kinazni inhibitorji
IL194583A0 (en) Imidazo compounds
PL2004654T3 (pl) Pochodne pirazolopirymidyny do stosowania jako antagonisty kinazy
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
IL187657A0 (en) Substituted arylpyrazoles for use against parasitites
AP2009004790A0 (en) Pyrido (2,3-D) Pyrimidinone compounds and their use as P13 inhibitors
SI2124944T1 (sl) Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze
EP2224803A4 (fr) Spiropipéridines utilisables en tant qu'inhibiteurs de la tryptase
EP2012791A4 (fr) 7,9-dihydro-purin-8-one et analogues associés utilisés en tant qu'inhibiteurs de hsp90
EP2142542A4 (fr) Nouveaux composés d'imidazo [4,5-b] pyridine-7-carboxamides 704
SI2004654T1 (sl) Pirazolopirimidinski derivati za uporabo kot kinazni antagonisti
GB0810059D0 (en) Paint supply system
ZA200906166B (en) 2-amino-5, 7-dihydro-6H-pyrrolo [3, 4-D] pyrimidine derivatives as HSP-90 inhibitors for treating cancer
GB0519245D0 (en) Purine compounds
PT1849360E (pt) Novo uso para ácido 2-hidroxi-4-metiltiobutanóico (hmtb)